razoxane has been researched along with Sensitivity and Specificity in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Klimes, J; Kovarikova, P; Pasakova-Vrbatova, I; Simunek, T; Stariat, J; Vavrova, A | 1 |
| Lipshultz, SE; Lipsitz, SR; Orav, EJ | 1 |
| Alberts, DS; Dawson, BV; Dorr, RT; Hendrix, M; Shipp, NG | 1 |
| Arundell, E; Bates, M; Lieu, D; Tonkin, K; Williamson, T; Zagari, M | 1 |
| Carlson, RW | 1 |
| Baldwin, JR; Lewis, RC; Narang, PK; Phillips, BA; Rossi, DT | 1 |
1 trial(s) available for razoxane and Sensitivity and Specificity
| Article | Year |
|---|---|
Dexrazoxane cardioprotection for patients receiving FAC chemotherapy: a pharmacoeconomic evaluation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cardiovascular Agents; Cost-Benefit Analysis; Cyclophosphamide; Decision Support Techniques; Doxorubicin; Economics, Pharmaceutical; Female; Fluorouracil; Health Care Costs; Heart; Heart Diseases; Humans; Markov Chains; Middle Aged; Models, Economic; Neoplasm Staging; Razoxane; Sensitivity and Specificity | 1996 |
5 other study(ies) available for razoxane and Sensitivity and Specificity
| Article | Year |
|---|---|
Development of LC-MS/MS method for the simultaneous analysis of the cardioprotective drug dexrazoxane and its metabolite ADR-925 in isolated cardiomyocytes and cell culture medium.
Topics: Animals; Animals, Newborn; Cardiovascular Agents; Cells, Cultured; Chromatography, Liquid; Ethylenediamines; Glycine; Myocytes, Cardiac; Pilot Projects; Rabbits; Rats; Rats, Wistar; Razoxane; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2013 |
Dexrazoxane-associated risk for secondary malignancies in pediatric Hodgkin's disease: a claim without compelling evidence.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Hodgkin Disease; Humans; Incidence; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes; Neoplasms, Second Primary; Randomized Controlled Trials as Topic; Razoxane; Risk Assessment; Scientific Misconduct; Sensitivity and Specificity; Survival Rate | 2007 |
Characterization of experimental mitoxantrone cardiotoxicity and its partial inhibition by ICRF-187 in cultured neonatal rat heart cells.
Topics: Adenosine Triphosphate; Animals; Cells, Cultured; Dose-Response Relationship, Drug; Heart Diseases; Humans; Leukemia, Experimental; Male; Mice; Mice, Inbred DBA; Microscopy, Electron; Mitoxantrone; Multiple Myeloma; Myocardium; Rats; Rats, Sprague-Dawley; Razoxane; Sensitivity and Specificity; Tumor Cells, Cultured | 1993 |
Reducing the cardiotoxicity of the anthracyclines.
Topics: Antibiotics, Antineoplastic; Biopsy, Needle; Endocardium; Heart Diseases; Heart Failure; Heart Function Tests; Humans; Myocardium; Neoplasms; Razoxane; Risk Factors; Sensitivity and Specificity | 1992 |
A sensitive and specific procedure for quantitation of ADR-529 in biological fluids by high-performance liquid chromatography (HPLC) with column switching and amperometric detection.
Topics: Chromatography, High Pressure Liquid; Drug Stability; Electrochemistry; Quality Control; Razoxane; Reproducibility of Results; Sensitivity and Specificity | 1992 |